Navigation Links
Terumo to Sponsor Presentations on Key Issues in Cardiac and Vascular Surgery at Society of Thoracic Surgeons Annual Meeting
Date:1/20/2010

ANN ARBOR, Mich., Jan. 20 /PRNewswire/ -- Terumo announced it has finalized its agenda of sponsored presentations at the Annual Meeting of the Society of Thoracic Surgeons (STS) in Fort Lauderdale, Florida, January 24-27.  The presentations cover topics currently of heightened interest in the cardiovascular community: controversies in aortic surgery procedures, the debate over endoscopic vein harvesting, and the role of minimized perfusion circuits in blood management.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )

Terumo will be represented at the STS by its three subsidiaries that develop, manufacture and market products for cardiac and vascular surgery: Terumo Cardiovascular Systems (Terumo CVS) produces products for cardiopulmonary bypass, endoscopic vessel harvesting and intraoperative monitoring; Terumo Heart Inc. produces the DuraHeart™ Left Ventricular Assist System, currently in clinical trials in the U.S.; Vascutek Ltd. is a leading manufacturer of vascular grafts.   All product lines will be represented at the Terumo exhibit.

"The STS Annual Meeting is an important venue for Terumo," said Mark Sutter, President and CEO of Terumo Cardiovascular Systems.  "It is one of the best opportunities for clinicians and industry to come together and exchange information that is relevant to advancing cardiovascular surgery.  We are pleased to support that goal by sponsoring these speakers."

Terumo CVS and Vascutek are co-sponsoring a dinner symposium on Sunday, January 24 entitled, "Great Debates: Five Controversies in Aortic Surgery." The program features ten world renowned cardiovascular surgeons presenting opposing viewpoints on five current topics in aortic surgery.  The program is moderated by Joseph Bavaria, MD, Vice Chief, Division of Cardiothoracic Surgery, University of Pennsylvania Health System.  More information on the program can be found at www.terumo-cvs.com/greatdebates2010.

On Monday, January 25, Kourosh Asgarian, DO, FACS, Staten Island University Hospital, presents his views favoring the use of endoscopic vein harvesting (EVH) in a presentation called "Conduit Quality Counts: In Support of EVH."  The presentation is in response to the ongoing debate in the surgical community over the merits of EVH.  The debate was initiated last summer by a study published in the New England Journal of Medicine.

Also at the Terumo exhibit on Monday, Ingo Kutschka, MD, Hannover Medical School, Germany, presents "Minimized Circuit Technology Improves Patient Outcomes." Dr. Kutschka is involved in a multi-center European trial; preliminary results of the trial, presented at the 2009 Annual Meeting of the European Association of Cardiothoracic Surgery, suggest an association between the use of Terumo's reservoir-less circuit technology and reductions in blood transfusions and post-operative atrial fibrillation.

Terumo estimates that its products are used in more than 1000 cardiac and vascular surgeries every day, including coronary artery bypass grafting, valve replacements, heart transplants, aortic aneurysm repair, and surgeries for peripheral artery disease.  

About Terumo's Cardiac and Vascular Surgery Subsidiaries

Terumo Cardiovascular Systems Corporation is a global manufacturer and marketer of medical devices for cardiac and vascular surgery.  The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; and Ashland, Massachusetts.  For more information, visit www.terumo-cvs.com.

Terumo Heart, Inc. has headquarters and manufacturing facilities in Ann Arbor, Michigan.  The company's focus is the innovation and introduction of products to improve the quality of healthcare for heart failure patients.  The DuraHeart system is limited to investigational use only in the United States, and is CE marked in Europe.  For more information, visit www.terumoheart.com.

Vascutek Ltd., based outside of Glasgow, Scotland, is one of the world's leading designers, manufacturers and marketers of vascular products for the treatment of cardiovascular disease, including a wide range of sealed and unsealed knitted and woven polyester and ePTFE vascular prosthetic grafts.  For more information, visit www.vascutek.com.  

Terumo Corporation is a premier global medical device company with annual sales of more than three billion dollars for the year ending March 31, 2009.  Founded in 1921, the company develops, manufactures and distributes world-class medical devices for use in cardiothoracic surgery, interventional procedures, transfusion medicine, and needle and syringe products.  

SOURCE Terumo Cardiovascular Systems

RELATED LINKS
http://www.terumo-cvs.com

'/>"/>

SOURCE Terumo Cardiovascular Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
2. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
3. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
4. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
5. Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants
6. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
7. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
8. Baxa Corporation to Sponsor Free Culture of Safety Webinar
9. NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit
10. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
11. AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... New Jersey , April 29, 2016 /PRNewswire/ ... Software Suite for Life Sciences, Product Development Capabilities ... Global Life Science Customer Base . ... solutions provider, today announced the acquisition of Skura ... a global leader in adaptive sales enablement technology ...
(Date:4/28/2016)... 28, 2016   Click here for supplemental ... (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ... agreement to acquire Valley Campus Pharmacy, Inc., doing ... leading specialty pharmacy that provides individualized patient care, ... . In 2015, TNH generated approximately $400 million ...
(Date:4/28/2016)... April 28, 2016 ... George Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter ... heute bekannt, dass neue Führungskräfte zum Team ... sind, die vielfältige Erfahrungen mitbringen.  Dies wird ...
Breaking Medicine Technology:
(Date:4/29/2016)... , ... April 29, 2016 , ... Spine Team Texas, ... is proud to announce one of their physicians has been invited to be a ... (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, ... ... integrated manufacturer and engineer of patented products, announces the Gyrociser, an exercise invention ... industry is worth $2 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:4/29/2016)... ... , ... Dr. Robert Mondavi, one of the dentists in Torrance , ... fast-growing field as more patients are discovering the many different ways they can change ... currently available to them and which ones might work for their smiles. , ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored 94.8124 ... survey, earning them second place for Tampa’s Best Places to Work. They were ranked ... is a great accomplishment for our team,” says RMS Human Resources Manager Irene Miller. ...
Breaking Medicine News(10 mins):